Leaflet LERCARIL 20mg / 20mg film-coated tablets


Indicated for: hypertension

Substance: enalapril + lercanidipine (ACE inhibitor + calcium channel blocker)

ATC: C09BB02 (Cardiovascular system | Ace inhibitors, combinations | Ace inhibitors and calcium channel blockers)

The combination of Enalaprilum + Lercanidipinum is used for the treatment of essential hypertension in patients requiring combination therapy. It combines an angiotensin-converting enzyme (ACE) inhibitor (enalaprilum) with a calcium channel blocker (lercanidipinum) to lower blood pressure.

The medication is taken orally, usually once daily, and is effective in reducing the risk of cardiovascular complications such as stroke or heart attack.

Side effects may include dizziness, headache, peripheral edema, dry cough, or nausea. It is important to monitor blood pressure and kidney function during treatment.

Consult your doctor to discuss the benefits and risks of treatment with this combination. Follow the prescribed dosage and adhere to all medical recommendations.

General data about LERCARIL 20mg / 20mg

  • Substance: enalapril + lercanidipine
  • Date of last drug list: 01-05-2026
  • Commercial code: W61013003
  • Concentration: 20mg / 20mg
  • Pharmaceutical form: film-coated tablets
  • Quantity: 28
  • Product type: original
  • Price: 33.50 RON
  • Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.

Marketing authorisation

  • Manufacturer: RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA S.P.A. - ITALIA
  • Holder: RECORDATI IRELAND LIMITED - IRLANDA
  • Number: 11505/2019/03
  • Shelf life: 2 years

Concentrations available for enalapril + lercanidipine

  • 10mg/10mg
  • 20mg/10mg
  • 20mg/20mg

Compensation lists for LERCARIL 20mg / 20mg Recordati

B - Sublist B with 50% discount from the reference price

Price

Copayment

Patient

33.50 RON

16.75 RON

16.75 RON